Publications by authors named "Seohyun Yoo"
Purpose: The objective of this study was to analyze proposed Korean nursing legislation as depicted in newspaper articles, to highlight issues related to the legislative process for this potential law, and to better understand social awareness regarding this matter.
Methods: The study focused on articles from 11 leading newspapers in Korea, published between February 2020 and August 2023, that pertained to nursing legislation. The articles were retrieved from the BigKinds database.
Article Synopsis
- Aquatic foods are recognized as a valuable source of nutrients for human nutrition, but inconsistencies in studies can lead to biased conclusions and poor policy decisions.
- A decision framework is proposed to select nutrients in aquatic food research, focusing on human physiological importance, the nutritional needs of specific populations, and nutrient availability compared to other food sources.
- The study highlights 41 key nutrients that are vital for health, emphasizes the unique benefits of aquatic foods, and suggests future research directions to enhance understanding of aquatic foods' role in nutrition security and public health.
Healthcare systems account for a substantial proportion of global carbon emissions and contribute to wider environmental degradation. This scoping review aimed to summarize the evidence currently available on incorporation of environmental and sustainability considerations into health technology assessments (HTAs) and guidelines to support the National In stitute for Health and Care Excellence and analogous bodies in other jurisdictions developing theirown methods and processes. Overall, 7,653 articles were identified, of which 24 were included in this review and split into three key areas - HTA (10 studies), healthcare guidelines (4 studies), and food and dietary guidelines (10 studies).
View Article and Find Full Text PDFEmergency Use Authorization (EUA) allows the US Food and Drug Administration (FDA) to expedite the availability of therapeutics in the context of a public health emergency. To date, an evidentiary standard for clinical efficacy to support an EUA has not yet been established. This review examines the clinical data submitted in support of EUA for antiviral and anti-inflammatory therapeutics for coronavirus disease 2019 (COVID-19) through December of 2021 and the resilience of the authorization as new clinical data arose subsequent to the authorization.
View Article and Find Full Text PDF